Product Information

ROPINIROLE HCL 0.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0430 per EA under NDC 62332003131. Its NADAC has been published 537 times since May 11, 2016.

FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROPINIROLE HCL 0.5 MG TABLET

ROPINIROLE
$0.0430per EA

Strength

.5 mg/1

NDC

62332003131

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROPINIROLE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090429

FDA Approved

3/24/2010

TE Code

AB

On Market Since

1/29/2016

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for ROPINIROLE HCL 0.5 MG TABLET has been published 537 times since May 11, 2016, and over the history we have for it it has declined 56.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0430 per EA
All-time high$0.0985 (May 11, 2016)
All-time low$0.0347 (Nov 20, 2024)
52-week high$0.0462
52-week low$0.0426
Median price$0.0561
Average price$0.0569
Largest weekly change-24.8% (Nov 20, 2024)
Weeks tracked537
Tracking sinceMay 11, 2016

Price History

1W

-0.1%

1M

-0.1%

3M

-1.0%

6M

-0.5%

1Y

-6.9%

3Y

-12.2%

5Y

-25.2%

All

-56.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ROPINIROLE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ROPINIROLE HCL 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0430 per EA (NDC 62332003131), effective Aug 19, 2026.

How has the price of ROPINIROLE HCL 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROPINIROLE HCL 0.5 MG TABLET has declined 56.3%. It has been tracked across 537 weekly CMS publications since May 11, 2016.

What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.5 MG TABLET?

Since May 11, 2016, the NADAC for ROPINIROLE HCL 0.5 MG TABLET has ranged from a low of $0.0347 (Nov 20, 2024) to a high of $0.0985 (May 11, 2016), with a median of $0.0561 per EA.

Are there cheaper alternatives to ROPINIROLE HCL 0.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ROPINIROLE HCL 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ROPINIROLE HCL 0.5 MG TABLET?

ROPINIROLE HCL 0.5 MG TABLET (NDC 62332003131) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.